We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PSNL market cap is 79.29M. The company's latest EPS is USD -2.1443 and P/E is -0.72.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.86M | 16.72M | 18.86M | 16.7M | 18.25M |
| Operating Income | -27.26M | -32.09M | -29.83M | -25.35M | -25.23M |
| Net Income | -26.49M | -31.07M | -28.66M | -23.96M | -29.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 65.21M | 78.65M | 85.49M | 65.05M | 73.48M |
| Operating Income | -22.42M | -42.15M | -65.35M | -115.53M | -104.37M |
| Net Income | -25.08M | -41.28M | -65.23M | -113.32M | -108.3M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 317.86M | 292.7M | 272.18M | 249.04M | 226.64M |
| Total Liabilities | 75.46M | 74.56M | 78.55M | 72.95M | 75.43M |
| Total Equity | 242.4M | 218.14M | 193.63M | 176.09M | 151.21M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 157.29M | 244.84M | 396.53M | 292.7M | 225.1M |
| Total Liabilities | 50.6M | 49.9M | 86.23M | 74.56M | 95.66M |
| Total Equity | 106.69M | 194.95M | 310.3M | 218.14M | 129.44M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -53.47M | -70.23M | -15.75M | -26.16M | -42.84M |
| Investing | 30.69M | 52.54M | 13.79M | 33.34M | 24.74M |
| Financing | 855k | 1.37M | N/A | 925k | 1.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.07M | -42.65M | -70.83M | -70.23M | -56.26M |
| Investing | -81.58M | -65.14M | -60.07M | 52.54M | 13.1M |
| Financing | 134.95M | 121.27M | 169.7M | 1.37M | 11.03M |
| Market Cap | 79.29M |
| Price to Earnings Ratio | -0.72 |
| Price to Sales Ratio | 1.07 |
| Price to Cash Ratio | 1.37 |
| Price to Book Ratio | 0.6 |
| Dividend Yield | - |
| Shares Outstanding | 50.5M |
| Average Volume (1 week) | 215.38k |
| Average Volume (1 Month) | 213.06k |
| 52 Week Change | -30.22% |
| 52 Week High | 2.60 |
| 52 Week Low | 0.8906 |
| Spread (Intraday) | 0.85 (45.95%) |
| Company Name | Personalis Inc |
| Address |
3500 south dupont highway dover, delaware 19901 |
| Website | https://www.personalis.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
